All Insights

Life Sciences and Healthcare

The US BIOSECURE Act: is your supply chain at risk?

The legislation could be enacted by the end of the year, with potentially wide-ranging consequences for biotech companies undertaking federal
Digital Regulation

Digital Omnibus reshapes EU cookie rules but leaves banner fatigue largely intact

The Digital Omnibus Proposal promises a cleaner, GDPR-based framework for cookies and consent, yet its narrow exemptions and technical fixes
Energy and Energy Transition

The Energy Transition | UK government consults on raft of changes to the Capacity Market

Welcome to our top picks of the latest energy regulatory and market developments in the UK's transition to net zero
Life Sciences and Healthcare

EU triggers mandatory Eudamed use for diagnostics and medtech from May 2026

First modules declared functional under phased approach, with vigilance and clinical studies still to follow
Workforce Solutions

Umbrella company tax reform has landed in the UK

The government's umbrella company tax reforms are now final and will take effect on 6 April 2026 – time to
Financial regulation

The EU's SFDR 2.0 – what do asset managers need to know?

The European Commission has published its proposals for a significant overhaul of the EU’s sustainable finance disclosure framework
Business crime

UK Serious Fraud Office publishes guidance on how it will evaluate corporate compliance programmes

SFO sets expectations on compliance, cooperation and failure to prevent fraud
Competition, antitrust and trade

New EU economic‑security roadmap resets the bar for foreign investment into Europe

European Commission tightens foreign investment scrutiny, with plans to monitor portfolio investments for the first time
Life Sciences and Healthcare

Medical devices, diagnostics and pharma win concessions in EU Digital Omnibus proposal

Commission acknowledges implementation challenges, adjusts high-risk AI requirements for the life sciences sector
IT and data

The implementation of the NIS-2 Directive in Germany – What are the deviations from the NIS-2 Directive?

Germany’s NIS-2 Act is in force now narrowing scope and adding a ‘critical’ tier compared to the NIS-2 Directive. With
Corporate

AIMing high, acting fast: the London Stock Exchange's feedback statement plans to revitalise AIM with immediate rule changes

LSE acts to introduce immediate flexibilities and a clear roadmap to a fuller rulebook consultation in the first half of